Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder

Brain, Behavior, and Immunity

Volumn 34, Issue , 2013, Pages 47-55

  Wieck, Andrea ^a   Grassi Oliveira, Rodrigo ^a   do Prado, Carine Hartmann ^a   Rizzo, Lucas Bortolotto ^a   de Oliveira, Agatha Schommer ^a   Kommers Molina, Júlia ^a   Viola, Thiago Wendt ^a   Teixeira, AntÔnio Lúcio ^b   Bauer, Moisés Evandro ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bipolar disorder; Inflammation; Lymphocyte subsets; MAPK; NF kappa B; Psychosocial stress

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ACUTE STRESS; ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR DISORDER 1; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; FEMALE; FLOW CYTOMETRY; HEART RATE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INTRACELLULAR SIGNALING; MENTAL STRESS; NERVOUS SYSTEM FUNCTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SALIVA ANALYSIS; SALIVA LEVEL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

BIPOLAR DISORDER; INFLAMMATION; LYMPHOCYTE SUBSETS; MAPK; NF-KAPPA B; PSYCHOSOCIAL STRESS;

ADULT; BIPOLAR DISORDER; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; LYMPHOCYTE ACTIVATION; MIDDLE AGED; NEUROSECRETORY SYSTEMS; STRESS, PSYCHOLOGICAL;

EID: 84885023859     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.07.005     Document Type: Article

References (54)

1. Ahrens T., Deuschle M., Krumm B., van der Pompe G., den Boer J.A., Lederbogen F. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosom. Med. 2008, 70:461-467.
2. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-290.
3. Barbosa I.G., Huguet R.B., Mendonca V.A., Sousa L.P., Neves F.S., Bauer M.E., Teixeira A.L. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261:139-143.
4. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. USA 2003, 100:1920-1925.
5. Breunis M.N., Kupka R.W., Nolen W.A., Suppes T., Denicoff K.D., Leverich G.S., Post R.M., Drexhage H.A. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biol. Psychiatry 2003, 53:157-165.
6. Brietzke E., Stertz L., Fernandes B.S., Kauer-Sant'anna M., Mascarenhas M., Escosteguy Vargas A., Chies J.A., Kapczinski F. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J. Affect. Disord. 2009, 116:214-217.
7. Buske-Kirschbaum A., Gierens A., Hollig H., Hellhammer D.H. Stress-induced immunomodulation is altered in patients with atopic dermatitis. J. Neuroimmunol. 2002, 129:161-167.
8. Buske-Kirschbaum A., Kern S., Ebrecht M., Hellhammer D.H. Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain Behav. Immun. 2007, 21:92-99.
9. Buske-Kirschbaum A., Ebrecht M., Hellhammer D.H. Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav. Immun. 2010, 24:1347-1353.
10. Chen G., Manji H.K. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr. Opin. Psychiatry 2006, 19:313-323.
11. Clark L., Iversen S.D., Goodwin G.M. Sustained attention deficit in bipolar disorder. Br. J. Psychiatry 2002, 180:313-319.
12. De Bosscher K., Schmitz M.L., Vanden Berghe W., Plaisance S., Fiers W., Haegeman G. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA 1997, 94:13504-13509.
13. De Bosscher K., Vanden Berghe W., Vermeulen L., Plaisance S., Boone E., Haegeman G. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. USA 2000, 97:3919-3924.
14. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19:269-301.
15. Dhabhar F.S. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009, 16:300-317.
16. Dickerson S.S., Gable S.L., Irwin M.R., Aziz N., Kemeny M.E. Social-evaluative threat and proinflammatory cytokine regulation: an experimental laboratory investigation. Psychol. Sci. 2009, 20:1237-1244.
17. do Prado C.H., Rizzo L.B., Wieck A., Lopes R.P., Teixeira A.L., Grassi-Oliveira R., Bauer M.E. Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder. Psychoneuroendocrinology 2013, 38:667-676.
18. Drexhage R.C., Hoogenboezem T.H., Versnel M.A., Berghout A., Nolen W.A., Drexhage H.A. The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav. Immun. 2011, 25:1206-1213.
19. Edwards K.M., Bosch J.A., Engeland C.G., Cacioppo J.T., Marucha P.T. Elevated macrophage migration inhibitory factor (MIF) is associated with depressive symptoms, blunted cortisol reactivity to acute stress, and lowered morning cortisol. Brain Behav. Immun. 2010, 24:1202-1208.
20. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 2003, 23:7311-7316.
21. Engel S.R., Creson T.K., Hao Y., Shen Y., Maeng S., Nekrasova T., Landreth G.E., Manji H.K., Chen G. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol. Psychiatry 2009, 14:448-461.
22. Furuno T., Nakanishi M. Neurotrophic factors increase tumor necrosis factor-alpha-induced nuclear translocation of NF-kappaB in rat PC12 cells. Neurosci. Lett. 2006, 392:240-244.
23. Ghazeeri G., Abdullah L., Abbas O. Immunological differences in women compared with men: overview and contributing factors. Am. J. Reprod. Immunol. 2011, 66:163-169.
24. Goldstein B.I., Kemp D.E., Soczynska J.K., McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J. Clin. Psychiatry 2009, 70:1078-1090.
25. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
26. Hill M.N., Miller G.E., Carrier E.J., Gorzalka B.B., Hillard C.J. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 2009, 34:1257-1262.
27. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
28. Kapczinski F., Vieta E., Andreazza A.C., Frey B.N., Gomes F.A., Tramontina J., Kauer-Sant'anna M., Grassi-Oliveira R., Post R.M. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 2008, 32:675-692.
29. Kim Y.K., Myint A.M., Lee B.H., Han C.S., Lee S.W., Leonard B.E., Steinbusch H.W. T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients. Psychiatry Res. 2004, 129:267-272.
30. Kim H.W., Rapoport S.I., Rao J.S. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol. Dis. 2010, 37:596-603.
31. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
32. Knijff E.M., Breunis M.N., van Geest M.C., Kupka R.W., Ruwhof C., de Wit H.J., Nolen W.A., Drexhage H.A. A relative resistance of T cells to dexamethasone in bipolar disorder. Bipolar Disord. 2006, 8:740-750.
33. Knijff E.M., Breunis M.N., Kupka R.W., de Wit H.J., Ruwhof C., Akkerhuis G.W., Nolen W.A., Drexhage H.A. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord. 2007, 9:743-753.
34. Koo J.W., Russo S.J., Ferguson D., Nestler E.J., Duman R.S. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. USA 2010, 107:2669-2674.
35. Kunz-Ebrecht S.R., Mohamed-Ali V., Feldman P.J., Kirschbaum C., Steptoe A. Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain Behav. Immun. 2003, 17:373-383.
36. Lopes R.P., Grassi-Oliveira R., de Almeida L.R., Stein L.M., Luz C., Teixeira A.L., Bauer M.E. Neuroimmunoendocrine interactions in patients with recurrent major depression, increased early life stress and long-standing posttraumatic stress disorder symptoms. Neuroimmunomodulation 2012, 19:33-42.
37. O'Brien S.M., Scully P., Scott L.V., Dinan T.G. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J. Affect. Disord. 2006, 90:263-267.
38. O'Donovan A., Sun B., Cole S., Rempel H., Lenoci M., Pulliam L., Neylan T. Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis. Markers 2011, 30:123-132.
39. Ortiz-Dominguez A., Hernandez M.E., Berlanga C., Gutierrez-Mora D., Moreno J., Heinze G., Pavon L. Immune variations in bipolar disorder: phasic differences. Bipolar Disord. 2007, 9:596-602.
40. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., Heim C.M. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 2006, 163:1630-1633.
41. Padmos R.C., Hillegers M.H., Knijff E.M., Vonk R., Bouvy A., Staal F.J., de Ridder D., Kupka R.W., Nolen W.A., Drexhage H.A. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatry 2008, 65:395-407.
42. Post R.M., Leverich G.S. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev. Psychopathol. 2006, 18:1181-1211.
43. Raman M., Chen W., Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 2007, 26:3100-3112.
44. Rao J.S., Harry G.J., Rapoport S.I., Kim H.W. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 2010, 15:384-392.
45. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 1994, 91:752-756.
46. Ritz T., Ayala E.S., Trueba A.F., Vance C.D., Auchus R.J. Acute stress-induced increases in exhaled nitric oxide in asthma and their association with endogenous cortisol. Am. J. Respir. Crit. Care Med. 2011, 183:26-30.
47. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
48. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., Baldwin A.S. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 1995, 15:943-953.
49. Spiliotaki M., Salpeas V., Malitas P., Alevizos V., Moutsatsou P. Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients. Psychoneuroendocrinology 2006, 31:748-760.
50. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 2011, 73:114-126.
51. Strniskova M., Barancik M., Ravingerova T. Mitogen-activated protein kinases and their role in regulation of cellular processes. Gen. Physiol. Biophys. 2002, 21:231-255.
52. Sun Y., Zhang L., Johnston N.L., Torrey E.F., Yolken R.H. Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder. Br. J. Psychiatry Suppl. 2001, 41:s137-141.
53. Vonk R., van der Schot A.C., Kahn R.S., Nolen W.A., Drexhage H.A. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?. Biol. Psychiatry 2007, 62:135-140.
54. Wolf J., Rohleder N., Bierhaus A., Nawroth P.P., Kirschbaum C. Determinants of the NF-kappaB response to acute psychosocial stress in humans. Brain Behav. Immun. 2009, 23:742-749.